These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 11023538)

  • 1. NAD(P)H:quinone oxidoreductase-dependent risk for colorectal cancer and its association with the presence of K-ras mutations in tumors.
    Lafuente MJ; Casterad X; Trias M; Ascaso C; Molina R; Ballesta A; Zheng S; Wiencke JK; Lafuente A
    Carcinogenesis; 2000 Oct; 21(10):1813-9. PubMed ID: 11023538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer.
    van der Logt EM; Bergevoet SM; Roelofs HM; Te Morsche RH; Dijk Yv; Wobbes T; Nagengast FM; Peters WH
    Mutat Res; 2006 Jan; 593(1-2):39-49. PubMed ID: 16039674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese.
    Hamajima N; Matsuo K; Iwata H; Shinoda M; Yamamura Y; Kato T; Hatooka S; Mitsudomi T; Suyama M; Kagami Y; Ogura M; Ando M; Sugimura Y; Tajima K
    Int J Clin Oncol; 2002 Apr; 7(2):103-8. PubMed ID: 12018106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population.
    Sameer AS; Shah ZA; Syeed N; Rasool R; Afroze D; Siddiqi MA
    Asian Pac J Cancer Prev; 2010; 11(1):209-13. PubMed ID: 20593958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H quinone oxidoreductase 1 codon 609 polymorphism and its association to colorectal cancer.
    Harth V; Donat S; Ko Y; Abel J; Vetter H; Brüning T
    Arch Toxicol; 2000 Jan; 73(10-11):528-31. PubMed ID: 10663383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
    Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
    Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population.
    Zhang J; Schulz WA; Li Y; Wang R; Zotz R; Wen D; Siegel D; Ross D; Gabbert HE; Sarbia M
    Carcinogenesis; 2003 May; 24(5):905-9. PubMed ID: 12771035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract.
    Sarbia M; Bitzer M; Siegel D; Ross D; Schulz WA; Zotz RB; Kiel S; Geddert H; Kandemir Y; Walter A; Willers R; Gabbert HE
    Int J Cancer; 2003 Nov; 107(3):381-6. PubMed ID: 14506737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NQO1 C609T Polymorphism is Associated with Coronary Artery Disease in a Gender-Dependent Manner.
    Boroumand M; Pourgholi L; Goodarzynejad H; Ziaee S; Hajhosseini-Talasaz A; Sotoudeh-Anvari M; Mandegary A
    Cardiovasc Toxicol; 2017 Jan; 17(1):35-41. PubMed ID: 26690082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C609T inborn polymorphism in NAD(P)H:quinone oxidoreductase 1 is associated with susceptibility to multiple sclerosis and affects the risk of development of the primary progressive form of the disease.
    Stavropoulou C; Zachaki S; Alexoudi A; Chatzi I; Georgakakos VN; Terzoudi GI; Pantelias GE; Karageorgiou CE; Sambani C
    Free Radic Biol Med; 2011 Aug; 51(3):713-8. PubMed ID: 21605663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism.
    Wiencke JK; Spitz MR; McMillan A; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):87-92. PubMed ID: 9037558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms.
    Kracht T; Schrappe M; Strehl S; Reiter A; Elsner HA; Trka J; Cario G; Viehmann S; Harbott J; Borkhardt A; Metzler M; Langer T; Repp R; Marschalek R; Welte K; Haas OA; Stanulla M
    Haematologica; 2004 Dec; 89(12):1492-7. PubMed ID: 15590400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer].
    Zhang JH; Li Y; Wang R; Sarbia M; Guo W; Wen DG; Wei LZ; Chen ZF; Kuang G; Zhang LW; He M; Wu ML; Wang SJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Dec; 20(6):544-6. PubMed ID: 14669229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interaction between polymorphisms in NQO1(C609T) and XRCC1(G28152A) and their correlation with smoking on gastric cancer].
    Chen DJ; Ding R; Cao W; Ye DQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):5-8. PubMed ID: 21518531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
    Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
    Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of the NQO1 C609T Polymorphism in Non Small Cell Lung Adenocarcinoma Patients.
    Masroor M; Jain A; Javid J; Mir R; Prashant Y; Imtiyaz A; Mariyam Z; Mohan A; Ray PC; Saxena A
    Asian Pac J Cancer Prev; 2015; 16(17):7653-8. PubMed ID: 26625776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional NQO1 609C>T polymorphism and risk of hepatocellular carcinoma in a Chinese population.
    Liu F; Luo L; Wei Y; Wang W; Li B; Yan L; Wen T
    Tumour Biol; 2013 Feb; 34(1):47-53. PubMed ID: 22972504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.